Qiagen NV (QGEN) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

• Price: $49.07
• Market Cap: $10.02B
• P/E Ratio: 23.83
• EPS: $2.04
• 52-Week High: $57.82
• 52-Week Low: $35.53

Market Sentiment

Qiagen NV currently has a Bullish sentiment score of 0.40.

About Qiagen NV

Qiagen NV is a leading provider of sample-to-knowledge solutions that transform biological materials into actionable molecular insights, serving a diverse range of customers in the life sciences, clinical diagnostics, and pharmaceutical sectors. Headquartered in Venlo, the Netherlands, the company leverages advanced technologies to facilitate genomic and proteomic analysis, enabling researchers and clinicians to make informed decisions based on comprehensive molecular data. With a strong focu...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Qiagen NV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does QGEN pay dividends?

Qiagen NV (QGEN) does not currently pay a regular dividend.

What is QGEN's P/E ratio?

Qiagen NV has a price-to-earnings (P/E) ratio of 23.83.

What is QGEN's market cap?

Qiagen NV (QGEN) has a market capitalization of $10.02B with a current stock price of $49.07.